Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05300763 · ClinicalTrials.gov registry record · NA
Clinical Performance of Senofilcon A Investigational Lens
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 344
- Enrollment target
- 19
- Study locations
NCT05300763: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
NCT05300763 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 344 participants, above the 123-participant average among 20 other Visual Acuity trials with a reported enrollment target (180% higher). The trial reports 19 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05300763, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
- 19
- Study locations
Study Summary
This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.
Primary Outcome
End of day comfort was assessed using an individual item "Comfort at the End of the Day". Response set: Very Satisfied, Satisfied, Neither Satisfied nor Dissatisfied, Dissatisfied, and Very Dissatisfied.
Conditions Studied
Interventions
- DEVICE senofilcon A prototype
- DEVICE Dailies Total 1
Study Locations (19)
Florida
- Vue Optical Boutique - Jacksonville
- Dr. James Weber & Associates, PA - City Square Blvd - Jacksonville
- Stam & Associates Eye Care - Jacksonville
- Sabal Eye Care - Longwood
- Maitland Vision Center - North Orlando Ave - Maitland
- Flora Chen Poveda, OD, PA - Orange Park - Orange Park
- Southwest Orlando Eye Care - Orlando
- Tallahassee Eye Center - Tallahassee
Tennessee
- Optometry Group, LLC - Memphis
- Total Eye Care - Memphis
California
- Randall Go, OD - San Francisco
Georgia
- VisualEyes - Roswell
Kansas
- Kannarr Eye Care - Pittsburg
Michigan
- Birmingham Vision Care - Bloomfield
New York
- Sacco Eye Group - Vestal
Ohio
- ProCare Vision Centers - Granville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2022-05-25 |
| Phase | NA |
What the finished NCT05300763 record still lists
NCT05300763 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, above the 123-participant average among 20 other Visual Acuity trials with a reported enrollment target (180% higher).
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A prototype is the first listed.
NCT05300763 lists 19 locations in 11 states (Florida, Tennessee, California).
Frequently Asked Questions
What is clinical trial NCT05300763 about?
NCT05300763 is a clinical study titled "Clinical Performance of Senofilcon A Investigational Lens". This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.
What is the current status of trial NCT05300763?
This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2022-03-21. Estimated completion is 2022-05-25.
What conditions does trial NCT05300763 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT05300763?
The interventions under investigation include: senofilcon A prototype (DEVICE), Dailies Total 1 (DEVICE).
Who is sponsoring clinical trial NCT05300763?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05300763 being conducted?
This trial has 19 study locations across California, Florida, Georgia, Kansas, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05300763's enrollment target sits among peer trials
344 2nd of 20 the highest of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI